Article info
Letter
Onset of connective tissue disease following anti-PD1/PD-L1 cancer immunotherapy
- Correspondence to Professor Olivier Lambotte, CHU Bicêtre, APHP, Department of Internal Medicine and Clinical Immunology, 78 rue du Général Leclerc, Le Kremlin-Bicêtre F-94275, France; olivier.lambotte{at}aphp.fr
Citation
Onset of connective tissue disease following anti-PD1/PD-L1 cancer immunotherapy
Publication history
- Received November 13, 2016
- Revised January 26, 2017
- Accepted February 6, 2017
- First published February 27, 2017.
Online issue publication
April 19, 2018
Article Versions
- Previous version (12 February 2018).
- You are viewing the most recent version of this article.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/